Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
(Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 209.73%664.13K | 347.49%1.66M | 1,347.81%3.72M | 1.96M | 860.91%1.12M | 228.63%214.42K | 475.30%371.29K | 256.75K | 116.61K | 65.25K |
Selling and administrative expenses | 209.73%664.13K | 347.49%1.66M | 1,347.81%3.72M | --1.96M | 860.91%1.12M | 228.63%214.42K | 475.30%371.29K | --256.75K | --116.61K | --65.25K |
-General and administrative expense | 209.73%664.13K | 347.49%1.66M | 1,347.81%3.72M | --1.96M | 860.91%1.12M | 228.63%214.42K | 475.30%371.29K | --256.75K | --116.61K | --65.25K |
Operating profit | -209.73%-664.13K | -347.49%-1.66M | -1,347.81%-3.72M | -1.96M | -860.91%-1.12M | -228.63%-214.42K | -475.30%-371.29K | -256.75K | -116.61K | -65.25K |
Net non-operating interest income expense | 11.33%1.37M | 424.26%2.04M | 11,949.89%3.05M | 4.07M | 75,538.27%2.43M | 1.23M | 390K | 25.29K | 3.21K | 0 |
Non-operating interest income | 11.33%1.37M | 424.26%2.04M | 11,949.89%3.05M | --4.07M | 75,538.27%2.43M | --1.23M | --390K | --25.29K | --3.21K | --0 |
Other net income (expense) | ||||||||||
Income before tax | -30.60%704.16K | 1,948.13%383.1K | -189.37%-669.78K | 2.11M | 1,253.60%1.31M | 1,655.03%1.01M | 128.98%18.71K | -231.46K | -113.4K | -65.25K |
Income tax | 23.54%276.75K | 418.78K | 629.63K | 812.47K | 588.45K | 224.02K | 0 | 0 | 0 | 0 |
Net income | -45.94%427.4K | -290.74%-35.68K | -461.39%-1.3M | 1.3M | 734.69%719.75K | 1,311.69%790.6K | 128.98%18.71K | -231.46K | -113.4K | -65.25K |
Net income continuous Operations | -45.94%427.4K | -290.74%-35.68K | -461.39%-1.3M | --1.3M | 734.69%719.75K | 1,311.69%790.6K | 128.98%18.71K | ---231.46K | ---113.4K | ---65.25K |
Minority interest income | ||||||||||
Net income attributable to the parent company | -45.94%427.4K | -290.74%-35.68K | -461.39%-1.3M | 1.3M | 734.69%719.75K | 1,311.69%790.6K | 128.98%18.71K | -231.46K | -113.4K | -65.25K |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -45.94%427.4K | -290.74%-35.68K | -461.39%-1.3M | 1.3M | 734.69%719.75K | 1,311.69%790.6K | 128.98%18.71K | -231.46K | -113.4K | -65.25K |
Basic earnings per share | ||||||||||
Diluted earnings per share | ||||||||||
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |